What is SpyGlass Pharma, Inc.?
operates as a biopharmaceutical company that provides treatment and drug delivery for patients living with chronic eye conditions.
The story behind the price, the case for and against, and what could go wrong. Open a part to read it.
operates as a biopharmaceutical company that provides treatment and drug delivery for patients living with chronic eye conditions. The company develops the Bimatoprost Drug Pad-IOL System (BIM-IOL System), including novel and proprietary drug pads attached to an intraocular lens (IOL), which is designed to be implanted during routine cataract surgery to reduce elevated intraocular pressure (IOP) in patients. The company is listed on the NASDAQ in USA, operating in the Healthcare sector, with a market capitalisation of 1.10B.
A short list of Biotechnology names that are close enough in size to make side-by-side comparison useful.